New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer
Nature Clinical Practice Oncology · 2009-01 · 6 (1) · 25-33
DOI: 10.1038/ncponc1243 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nature Clinical Practice Oncology, online erschienen am 21.10.2008. Verfasst von Michelle E Melisko und 2 weiteren Autor:innen. Beteiligte Einrichtung: Breast Oncology Clinical Trials Program, UCSF Comprehensive Cancer Center, University of California-San Francisco, 1600 Divisadero Street, San Franci…. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 75 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Breast Oncology Clinical Trials Program, UCSF Comprehensive Cancer Center, University of California-San Francisco, 1600 Divisadero Street, San Francisco, CA 94115-1710, USA. michelle.melisko@ucsf.edu
Zitieren
APA
Melisko, M. E., Glantz, M., & Rugo, H. S. (2009). New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer. Nature Clinical Practice Oncology, 6(1), 25-33. https://doi.org/10.1038/ncponc1243
Vancouver
Melisko ME, Glantz M, Rugo HS. New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer. Nature Clinical Practice Oncology. 2009;6(1):25-33. doi:10.1038/ncponc1243
BibTeX
@article{Melisko2009,
author = {Melisko, Michelle E and Glantz, Michael and Rugo, Hope S},
title = {New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer},
journal = {Nature Clinical Practice Oncology},
year = {2009},
volume = {6},
number = {1},
pages = {25--33},
doi = {10.1038/ncponc1243}
}
EUVIMED